ZNF565 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.341700E-02
Normal-vs-Stage2
3.807400E-01
Normal-vs-Stage3
7.978400E-01
Normal-vs-Stage4
1.303770E-02
Stage1-vs-Stage2
1.471420E-01
Stage1-vs-Stage3
2.150800E-01
Stage1-vs-Stage4
6.359200E-03
Stage2-vs-Stage3
5.306600E-01
Stage2-vs-Stage4
1.672490E-02
Stage3-vs-Stage4
3.152400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.064400E-01
Normal-vs-AfricanAmerican
4.947600E-01
Normal-vs-Asian
3.029400E-01
Caucasian-vs-AfricanAmerican
7.963800E-01
Caucasian-vs-Asian
4.470200E-01
AfricanAmerican-vs-Asian
4.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.340400E-01
Normal-vs-Female
3.477400E-01
Male-vs-Female
6.481600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.890200E-01
Normal-vs-Age(41-60Yrs)
2.991400E-01
Normal-vs-Age(61-80Yrs)
4.293200E-01
Normal-vs-Age(81-100Yrs)
5.965800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.674800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.926800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.189200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.065400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.444800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.726600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.740200E-01
Normal-vs-Daily Drinker
6.986000E-01
Normal-vs-Weekly Drinker
3.313000E-01
Normal-vs-Occasional Drinker
2.982200E-01
Normal-vs-Social Drinker
2.383000E-01
Non Drinker-vs-Daily Drinker
8.043400E-01
Non Drinker-vs-Weekly Drinker
1.924160E-01
Non Drinker-vs-Occasional Drinker
1.620970E-01
Non Drinker-vs-Social Drinker
3.728600E-01
Daily Drinker-vs-Weekly Drinker
1.298440E-01
Daily Drinker-vs-Occasional Drinker
1.566030E-01
Daily Drinker-vs-Social Drinker
3.161000E-01
Weekly Drinker-vs-Occasional Drinker
7.514600E-01
Weekly Drinker-vs-Social Drinker
4.485600E-01
Occasional Drinker-vs-Social Drinker
5.859000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.056580E-01
Normal-vs-Grade 2
1.308450E-02
Normal-vs-Grade 3
1.882450E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.276440E-02
Grade 1-vs-Grade 3
5.724200E-02
Grade 1-vs-Grade 4
1.056580E-01
Grade 2-vs-Grade 3
6.445800E-01
Grade 2-vs-Grade 4
1.308450E-02
Grade 3-vs-Grade 4
1.882450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.304600E-01
Normal-vs-NonDiabetic
3.530600E-01
Diabetic-vs-NonDiabetic
7.062000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.861800E-01
Normal-vs-NoPancreatitis
4.629800E-01
Pancreatitis-vs-NoPancreatitis
4.140600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.315400E-01
Normal-vs-N1
3.908200E-01
N0-vs-N1
8.165800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.154160E-01
Normal-vs-TP53-NonMutant
4.494800E-01
TP53-Mutant-vs-TP53-NonMutant
1.158150E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
